Serious Mental Illness and Smoking Cessation Treatment Utilization: the Role of Healthcare Providers.
Journal
The journal of behavioral health services & research
ISSN: 1556-3308
Titre abrégé: J Behav Health Serv Res
Pays: United States
ID NLM: 9803531
Informations de publication
Date de publication:
01 2021
01 2021
Historique:
pubmed:
8
5
2020
medline:
9
9
2021
entrez:
8
5
2020
Statut:
ppublish
Résumé
Healthcare provider barriers to cessation resources may be undercutting quit rates for smokers with serious mental illness (SMI). The study aim was to examine how providers influence cessation treatment utilization among smokers with SMI. Data were taken from a trial conducted among smokers in Minnesota Health Care Programs. The sample was split into groups of participants with SMI (n = 939) and without SMI (n = 1382). Analyses assessed whether the association between SMI and treatment utilization was mediated by healthcare provider-delivered treatment advice and healthcare provider bias. Results revealed higher rates of treatment utilization among smokers with SMI than those without SMI (45.9% vs 31.7%, p < 0.001); treatment advice and provider bias did not mediate this association. Subsequent individual regression analyses revealed positive associations between treatment advice and treatment utilization (β 0.21-0.25, p < 0.05), independent of SMI status. Strategies to increase low-income smokers' contacts with providers may reduce treatment utilization barriers among these smokers.
Identifiants
pubmed: 32378032
doi: 10.1007/s11414-020-09707-3
pii: 10.1007/s11414-020-09707-3
pmc: PMC7644603
mid: NIHMS1591939
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
63-76Subventions
Organisme : NCI NIH HHS
ID : R01 CA141527
Pays : United States
Organisme : NCI NIH HHS
ID : T32 CA163184
Pays : United States
Références
MMWR Morb Mortal Wkly Rep. 2013 Feb 8;62(5):81-7
pubmed: 23388551
Tob Control. 1997;6 Suppl 1:S70-7
pubmed: 9396129
Nicotine Tob Res. 2007 Jul;9(7):721-30
pubmed: 17577801
BMC Public Health. 2013 May 11;13:462
pubmed: 23663362
J Dual Diagn. 2015;11(2):145-50
pubmed: 25985201
Acta Psychiatr Scand. 2008 Sep;118(3):169-71
pubmed: 18699951
Am J Prev Med. 2018 May;54(5):620-629
pubmed: 29551324
Epidemiology. 1992 Mar;3(2):143-55
pubmed: 1576220
Addiction. 2008 Jan;103(1):146-54
pubmed: 18028247
Soc Psychiatry Psychiatr Epidemiol. 2014 Jul;49(7):1119-28
pubmed: 24556812
Am J Prev Med. 2008 Aug;35(2):158-76
pubmed: 18617085
Gen Hosp Psychiatry. 2006 Mar-Apr;28(2):145-53
pubmed: 16516065
Biol Psychiatry. 2008 Jun 1;63(11):1092-6
pubmed: 18096137
JAMA. 2010 Dec 8;304(22):2485-93
pubmed: 21139110
Can J Psychiatry. 2009 Jun;54(6):368-78
pubmed: 19527557
Psychol Med. 2015 Jan;45(1):11-27
pubmed: 24569086
Psychol Methods. 2013 Jun;18(2):137-50
pubmed: 23379553
J Gen Intern Med. 2004 Feb;19(2):101-10
pubmed: 15009789
MMWR Morb Mortal Wkly Rep. 2018 Jan 19;67(2):53-59
pubmed: 29346338
BMJ. 2005 May 14;330(7500):1122
pubmed: 15843427
BMC Public Health. 2014 Apr 09;14:337
pubmed: 24716466
J Psychoactive Drugs. 2007 Dec;39(4):487-97
pubmed: 18303706
J Consult Clin Psychol. 1996 Oct;64(5):1003-9
pubmed: 8916629
Thorax. 2016 May;71(5):446-53
pubmed: 26931362
Psychiatry Res. 2014 Aug 15;218(1-2):35-8
pubmed: 24774076
Am J Psychiatry. 2006 Nov;163(11):1934-42
pubmed: 17074945